GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecular Templates Inc (FRA:NZW) » Definitions » Debt-to-Equity

Molecular Templates (FRA:NZW) Debt-to-Equity : 1.55 (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Molecular Templates Debt-to-Equity?

Molecular Templates's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.00 Mil. Molecular Templates's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €8.35 Mil. Molecular Templates's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €5.40 Mil. Molecular Templates's debt to equity for the quarter that ended in Mar. 2024 was 1.55.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Molecular Templates's Debt-to-Equity or its related term are showing as below:

FRA:NZW' s Debt-to-Equity Range Over the Past 10 Years
Min: -26.35   Med: 0.25   Max: 12.12
Current: 1.55

During the past 13 years, the highest Debt-to-Equity Ratio of Molecular Templates was 12.12. The lowest was -26.35. And the median was 0.25.

FRA:NZW's Debt-to-Equity is ranked worse than
93.07% of 1068 companies
in the Biotechnology industry
Industry Median: 0.14 vs FRA:NZW: 1.55

Molecular Templates Debt-to-Equity Historical Data

The historical data trend for Molecular Templates's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecular Templates Debt-to-Equity Chart

Molecular Templates Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.17 0.46 0.73 -3.34 2.90

Molecular Templates Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.35 -1.54 1.88 2.90 1.55

Competitive Comparison of Molecular Templates's Debt-to-Equity

For the Biotechnology subindustry, Molecular Templates's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Molecular Templates's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Molecular Templates's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Molecular Templates's Debt-to-Equity falls into.



Molecular Templates Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Molecular Templates's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Molecular Templates's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Molecular Templates  (FRA:NZW) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Molecular Templates Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Molecular Templates's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Molecular Templates (FRA:NZW) Business Description

Traded in Other Exchanges
Address
9301 Amberglen Boulevard, Suite 100, Austin, TX, USA, 78729
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer.

Molecular Templates (FRA:NZW) Headlines

No Headlines